Skip to main content

Market Overview

Benzinga's M&A Chatter for Thursday September 19, 2013

Benzinga's M&A Chatter for Thursday September 19, 2013

The following are the M&A deals, rumors and chatter circulating on Wall Street for Thursday September 19, 2013

Bomarin Pharmaceutical Shares Spike Higher Pre-Market on Chatter of Roche Interest

The Rumor:
Shares of Bomarin Pharmaceutical (NASDAQ: BMRN) rose sharply in the pre-market Thursday on a report from Deal Reporter that Roche (OTC: RHHBY) could offer between $95 and $105 per share for the San Rafael, CA biotech company.

After Roche initially declined comment on the rumor, the comapany's CEO said the company was not raising financing for a deal. Wells Fargo commented BioMarin is not a clean fit for Roche.

Biomarin shares traded over $86 in the pre-market and closed at $78.39, a gain of just over 1%.

IBM Acquires Daeja Image Systems

The Deal:
IBM (NYSE: IBM) announced Thursday it has acquired Daeja Image Systems, Daeja is a privately held software company with headquarters in the UK. Terms of the deal were not disclosed.

IBM closed at $193.39 Thursday, a loss of $1.03.

Veeco to Acquire Synos Technology

The Deal:
Veeco Instruments (NASDAQ: VECO) announced Thursday that it has agreed to acquire Synos Technology, a privately-held designer and manufacturer of Fast Array Scanning Atomic Layer Deposition systems that enable the production of flexible organic light-emitting diode displays for mobile devices.

Veeco Instruments closed at $35.74 Thursday, a gain of 1.25%.


Related Articles (BMRN + IBM)

View Comments and Join the Discussion!

Posted-In: M&A News Rumors Movers Tech

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at